This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Merrill Lynch on PerkinElmer Deal


NEW YORK, NY, October 1, 2007 — PerkinElmer, Inc. and ViaCell, Inc. today announced the signing of a definitive agreement under which PerkinElmer will acquire ViaCell for approximately $300 million. Covington & Burling LLP advised Merrill Lynch & Co., financial advisor to PerkinElmer, on the transaction, which is expected to close in the fourth quarter of 2007.

PerkinElmer is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve quality of life. ViaCell is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. Merrill Lynch is one of the world's leading wealth management, capital markets and advisory companies, with offices in 38 countries and territories and total client assets of approximately $1.7 trillion.

The Covington corporate team, based in New York, included partner Jack Bodner and associate Andrew Ment.

Share this article: